These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. The Distribution of Prion Protein Allotypes Differs Between Sporadic and Iatrogenic Creutzfeldt-Jakob Disease Patients. Moore RA; Head MW; Ironside JW; Ritchie DL; Zanusso G; Choi YP; Priola SA PLoS Pathog; 2016 Feb; 12(2):e1005416. PubMed ID: 26840342 [TBL] [Abstract][Full Text] [Related]
64. Modulation of Creutzfeldt-Jakob disease prion propagation by the A224V mutation. Watts JC; Giles K; Serban A; Patel S; Oehler A; Bhardwaj S; Guan S; Greicius MD; Miller BL; DeArmond SJ; Geschwind MD; Prusiner SB Ann Neurol; 2015 Oct; 78(4):540-53. PubMed ID: 26094969 [TBL] [Abstract][Full Text] [Related]
65. Novel strain properties distinguishing sporadic prion diseases sharing prion protein genotype and prion type. Cracco L; Notari S; Cali I; Sy MS; Chen SG; Cohen ML; Ghetti B; Appleby BS; Zou WQ; Caughey B; Safar JG; Gambetti P Sci Rep; 2017 Jan; 7():38280. PubMed ID: 28091514 [TBL] [Abstract][Full Text] [Related]
67. Familial human prion diseases associated with prion protein mutations Y226X and G131V are transmissible to transgenic mice expressing human prion protein. Race B; Williams K; Hughson AG; Jansen C; Parchi P; Rozemuller AJM; Chesebro B Acta Neuropathol Commun; 2018 Feb; 6(1):13. PubMed ID: 29458424 [TBL] [Abstract][Full Text] [Related]
68. Change in the characteristics of ferritin induces iron imbalance in prion disease affected brains. Singh A; Qing L; Kong Q; Singh N Neurobiol Dis; 2012 Mar; 45(3):930-8. PubMed ID: 22182691 [TBL] [Abstract][Full Text] [Related]
69. Cross-sequence transmission of sporadic Creutzfeldt-Jakob disease creates a new prion strain. Kobayashi A; Asano M; Mohri S; Kitamoto T J Biol Chem; 2007 Oct; 282(41):30022-8. PubMed ID: 17709374 [TBL] [Abstract][Full Text] [Related]
70. Prion protein with an E200K mutation displays properties similar to those of the cellular isoform PrP(C). Rosenmann H; Talmor G; Halimi M; Yanai A; Gabizon R; Meiner Z J Neurochem; 2001 Mar; 76(6):1654-62. PubMed ID: 11259483 [TBL] [Abstract][Full Text] [Related]
71. Recent advances in the histo-molecular pathology of human prion disease. Baiardi S; Rossi M; Capellari S; Parchi P Brain Pathol; 2019 Mar; 29(2):278-300. PubMed ID: 30588685 [TBL] [Abstract][Full Text] [Related]
72. Transmission characteristics of heterozygous cases of Creutzfeldt-Jakob disease with variable abnormal prion protein allotypes. Ward A; Hollister JR; McNally K; Ritchie DL; Zanusso G; Priola SA Acta Neuropathol Commun; 2020 Jun; 8(1):83. PubMed ID: 32517816 [TBL] [Abstract][Full Text] [Related]
73. Human prion diseases: from Kuru to variant Creutzfeldt-Jakob disease. Sikorska B; Liberski PP Subcell Biochem; 2012; 65():457-96. PubMed ID: 23225013 [TBL] [Abstract][Full Text] [Related]
74. Transgenic mice recapitulate the phenotypic heterogeneity of genetic prion diseases without developing prion infectivity: Role of intracellular PrP retention in neurotoxicity. Chiesa R; Restelli E; Comerio L; Del Gallo F; Imeri L Prion; 2016 Mar; 10(2):93-102. PubMed ID: 26864450 [TBL] [Abstract][Full Text] [Related]
75. Sensitive detection of pathological seeds of α-synuclein, tau and prion protein on solid surfaces. Orrú CD; Groveman BR; Hughson AG; Barrio T; Isiofia K; Race B; Ferreira NC; Gambetti P; Schneider DA; Masujin K; Miyazawa K; Ghetti B; Zanusso G; Caughey B PLoS Pathog; 2024 Apr; 20(4):e1012175. PubMed ID: 38640117 [TBL] [Abstract][Full Text] [Related]
76. Validation of Poly(Propylene Imine) Glycodendrimers Towards Their Anti-prion Conversion Efficiency. Schmitz M; Candelise N; Kanata E; Llorens F; Thüne K; Villar-Piqué A; da Silva Correia SM; Dafou D; Sklaviadis T; Appelhans D; Zerr I Mol Neurobiol; 2020 Apr; 57(4):1863-1874. PubMed ID: 31848935 [TBL] [Abstract][Full Text] [Related]
77. Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. Zou WQ; Puoti G; Xiao X; Yuan J; Qing L; Cali I; Shimoji M; Langeveld JP; Castellani R; Notari S; Crain B; Schmidt RE; Geschwind M; Dearmond SJ; Cairns NJ; Dickson D; Honig L; Torres JM; Mastrianni J; Capellari S; Giaccone G; Belay ED; Schonberger LB; Cohen M; Perry G; Kong Q; Parchi P; Tagliavini F; Gambetti P Ann Neurol; 2010 Aug; 68(2):162-72. PubMed ID: 20695009 [TBL] [Abstract][Full Text] [Related]
78. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality. Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465 [TBL] [Abstract][Full Text] [Related]
79. Epitope mapping of the protease resistant products of RT-QuIC does not allow the discrimination of sCJD subtypes. Piconi G; Peden AH; Barria MA; Green AJE PLoS One; 2019; 14(6):e0218509. PubMed ID: 31206560 [TBL] [Abstract][Full Text] [Related]
80. Identification of distinct N-terminal truncated forms of prion protein in different Creutzfeldt-Jakob disease subtypes. Zanusso G; Farinazzo A; Prelli F; Fiorini M; Gelati M; Ferrari S; Righetti PG; Rizzuto N; Frangione B; Monaco S J Biol Chem; 2004 Sep; 279(37):38936-42. PubMed ID: 15247220 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]